Login
Home
Charts
Search
Watchlist
Products

Bombay Super Hybrid Seeds Ltd

BSHSL·NSE
85.57-0.08%Wed, 23 Sept '26 15:50

Bombay Super Hybrid Seeds Ltd

BSHSL
NSE
85.57
-0.08%
|Wed, 23 Sept '26 15:50
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
891Cr
Close
Close Price
84.92
Industry
Industry
Seeds/Tissue Culture/Bio Technology
PE
Price To Earnings
30.77
PS
Price To Sales
2.38
Revenue
Revenue
374Cr
Rev Gr TTM
Revenue Growth TTM
5.30%
PAT Gr TTM
PAT Growth TTM
4.10%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
3476301572812846153279866183
Growth YoY
Revenue Growth YoY%
60.610.7-15.834.4-16.467.552.4-2.4-4.8-23.544.719.4
Expenses
ExpensesCr
3167271432511840138238860165
Operating Profit
Operating ProfitCr
39414310615410717
OPM
OPM%
8.712.111.78.710.97.813.310.015.59.89.99.4
Other Income
Other IncomeCr
001011100001
Interest Expense
Interest ExpenseCr
111211221122
Depreciation
DepreciationCr
000000000010
PBT
PBTCr
283122951329415
Tax
TaxCr
01-1100010101
PAT
PATCr
273112941228414
Growth YoY
PAT Growth YoY%
82.63.563.94.531.930.834.810.38.2-14.04.516.5
NPM
NPM%
4.79.010.47.17.37.09.28.08.37.96.67.8
EPS
EPS
0.10.70.31.10.20.80.41.20.20.70.41.4
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
3476301572812846153279866183
Growth YoY
Revenue Growth YoY%
60.610.7-15.834.4-16.467.552.4-2.4-4.8-23.544.719.4
Expenses
ExpensesCr
3167271432511840138238860165
Operating Profit
Operating ProfitCr
39414310615410717
OPM
OPM%
8.712.111.78.710.97.813.310.015.59.89.99.4
Other Income
Other IncomeCr
001011100001
Interest Expense
Interest ExpenseCr
111211221122
Depreciation
DepreciationCr
000000000010
PBT
PBTCr
283122951329415
Tax
TaxCr
01-1100010101
PAT
PATCr
273112941228414
Growth YoY
PAT Growth YoY%
82.63.563.94.531.930.834.810.38.2-14.04.516.5
NPM
NPM%
4.79.010.47.17.37.09.28.08.37.96.67.8
EPS
EPS
0.10.70.31.10.20.80.41.20.20.70.41.4

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
631108275103171192228257359344374
Growth
Revenue Growth%
101.573.7-24.9-9.438.466.011.918.912.739.7-4.15.3
Expenses
ExpensesCr
62108797097163178206228326308336
Operating Profit
Operating ProfitCr
113469142228333637
OPM
OPM%
1.91.24.25.85.95.17.29.411.19.110.310.0
Other Income
Other IncomeCr
10000011311
Interest Expense
Interest ExpenseCr
111111235667
Depreciation
DepreciationCr
001122111122
PBT
PBTCr
012336111824282830
Tax
TaxCr
001110111222
PAT
PATCr
011236111722262729
Growth
PAT Growth%
575.0215.438.476.927.9117.681.159.832.418.90.94.1
NPM
NPM%
0.40.81.42.82.63.45.57.48.77.47.87.7
EPS
EPS
2.53.10.20.30.51.01.62.12.52.52.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
631108275103171192228257359344374
Growth
Revenue Growth%
101.573.7-24.9-9.438.466.011.918.912.739.7-4.15.3
Expenses
ExpensesCr
62108797097163178206228326308336
Operating Profit
Operating ProfitCr
113469142228333637
OPM
OPM%
1.91.24.25.85.95.17.29.411.19.110.310.0
Other Income
Other IncomeCr
10000011311
Interest Expense
Interest ExpenseCr
111111235667
Depreciation
DepreciationCr
001122111122
PBT
PBTCr
012336111824282830
Tax
TaxCr
001110111222
PAT
PATCr
011236111722262729
Growth
PAT Growth%
575.0215.438.476.927.9117.681.159.832.418.90.94.1
NPM
NPM%
0.40.81.42.82.63.45.57.48.77.47.87.7
EPS
EPS
2.53.10.20.30.51.01.62.12.52.52.8

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
3578101010101010
Reserves
ReservesCr
1314151829466894121
Current Liabilities
Current LiabilitiesCr
1114152040577583116120
Non Current Liabilities
Non Current LiabilitiesCr
4833321113
Total Liabilities
Total LiabilitiesCr
203138477398133162222254
Current Assets
Current AssetsCr
152429386490124154212243
Non Current Assets
Non Current AssetsCr
571099898911
Total Assets
Total AssetsCr
203138477398133162222254
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
3578101010101010
Reserves
ReservesCr
1314151829466894121
Current Liabilities
Current LiabilitiesCr
1114152040577583116120
Non Current Liabilities
Non Current LiabilitiesCr
4833321113
Total Liabilities
Total LiabilitiesCr
203138477398133162222254
Current Assets
Current AssetsCr
152429386490124154212243
Non Current Assets
Non Current AssetsCr
571099898911
Total Assets
Total AssetsCr
203138477398133162222254

Cash Flow

Standalone
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1-2-50-8-12-812-31-16
Investing Cash Flow
Investing Cash FlowCr
-3-2-3-1-10-3-2-76
Financing Cash Flow
Financing Cash FlowCr
257114710-93810
Net Cash Flow
Net Cash FlowCr
02-205-50000
Free Cash Flow
Free Cash FlowCr
-2-5-11-1-9-12-1111-34-19
CFO To PAT
CFO To PAT%
82.2-147.4-257.4-2.2-130.3-115.2-48.052.0-117.9-59.3
CFO To EBITDA
CFO To EBITDA%
51.5-49.8-123.5-1.0-87.2-87.8-37.440.6-95.1-44.4
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1-2-50-8-12-812-31-16
Investing Cash Flow
Investing Cash FlowCr
-3-2-3-1-10-3-2-76
Financing Cash Flow
Financing Cash FlowCr
257114710-93810
Net Cash Flow
Net Cash FlowCr
02-205-50000
Free Cash Flow
Free Cash FlowCr
-2-5-11-1-9-12-1111-34-19
CFO To PAT
CFO To PAT%
82.2-147.4-257.4-2.2-130.3-115.2-48.052.0-117.9-59.3
CFO To EBITDA
CFO To EBITDA%
51.5-49.8-123.5-1.0-87.2-87.8-37.440.6-95.1-44.4

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
8458491,4684,1213,8592,3341,268637891
Price To Earnings
Price To Earnings
40.531.825.339.2229.8104.948.023.930.8
Price To Sales
Price To Sales
11.38.28.621.516.99.13.51.92.4
Price To Book
Price To Book
4.13.65.110.468.529.812.14.96.8
EV To EBITDA
EV To EBITDA
197.5142.3172.3302.0181.883.741.620.926.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
8.711.514.312.410.713.614.016.513.416.016.0
OPM
OPM%
1.91.24.25.85.95.17.29.411.19.110.310.0
NPM
NPM%
0.40.81.42.82.63.45.57.48.77.47.87.7
ROCE
ROCE%
12.412.211.312.312.516.419.122.317.414.614.6
ROE
ROE%
18.814.410.111.420.026.629.828.425.220.420.4
ROA
ROA%
4.23.85.45.78.010.812.613.711.910.510.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
8458491,4684,1213,8592,3341,268637891
Price To Earnings
Price To Earnings
40.531.825.339.2229.8104.948.023.930.8
Price To Sales
Price To Sales
11.38.28.621.516.99.13.51.92.4
Price To Book
Price To Book
4.13.65.110.468.529.812.14.96.8
EV To EBITDA
EV To EBITDA
197.5142.3172.3302.0181.883.741.620.926.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
8.711.514.312.410.713.614.016.513.416.016.0
OPM
OPM%
1.91.24.25.85.95.17.29.411.19.110.310.0
NPM
NPM%
0.40.81.42.82.63.45.57.48.77.47.87.7
ROCE
ROCE%
12.412.211.312.312.516.419.122.317.414.614.6
ROE
ROE%
18.814.410.111.420.026.629.828.425.220.420.4
ROA
ROA%
4.23.85.45.78.010.812.613.711.910.510.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Bombay Super Hybrid Seeds is a research-driven seed company built on a farmer’s instinct - its founder saw that India’s edible oilseed farmers had no access to good-quality packed seed, so he set out to fill that gap, starting with groundnut and sesame in 1983. The business has since grown from a single-farmer operation into a national enterprise with over 200 seed varieties, but the original logic still holds: it develops high-yielding hybrids in its own R&D farm, multiplies them through contract farmers, and sells them to cultivators across India through a network of distributors - all centred on crops where improved seed was scarce. # Business segments A single integrated engine - hybrid seed research, production, and marketing - where the company controls the full chain from lab to farm gate, with groundnut as the anchor crop. ## 1. Hybrid seed business: a full-stack seed factory for India’s oilseed and pulse farmers **The company breeds, multiplies, processes, and sells hybrid and high-yielding seeds - over 200 varieties across field and vegetable crops - with groundnut alone contributing roughly half of revenue.** - **Groundnut is the anchor** - the company deliberately chose edible oilseeds over cotton or vegetables because no good packed seed was available, and groundnut now accounts for about half of revenue, giving it a dominant position in a crop where India leads the world in acreage. - **A portfolio built for breadth, not just depth** - the product range has grown from more than 30 products in 2018-19 to over 200 varieties as of early 2025, spanning groundnut, soybean, pulses, maize, wheat, cumin, coriander, fodder crops, and cotton, so farmers can source multiple crop seeds from one supplier. - **Seeds bred for real-field stress** - the varieties are selected for high germination, disease resistance, drought tolerance, early maturity, and high oil content, which means farmers get a crop that can handle erratic weather and still deliver yield. - **Contract farming multiplies the seed** - the company gives parent seed to growers on leasehold land across India, pays them for cultivation, and then buys back the harvest, so it scales production without owning farmland. - **Processing that sorts seed like a factory** - the 85,000 sq. ft. processing unit in Rajkot runs Buhler Swiss machines that grade seeds by size, colour, and gravity, while 10,000 metric tonnes of cold storage keep inventory viable across seasons. ## 2. R&D and breeding engine: the lab that feeds the pipeline **An in-house DSIR-recognised research farm and a web of collaborations with global crop institutes - including ICRISAT and CIMMYT - generate the new varieties that keep the catalogue growing.** - **A 30-acre living laboratory** - the R&D farm at Kuchiyadad, Rajkot, includes a polyhouse for germplasm screening and nucleus seed production, so promising lines are tested and multiplied on site before they ever reach a contract farmer. - **Government recognition unlocks duty savings** - the Department of Scientific and Industrial Research (DSIR) has certified the R&D unit, which means the company imports equipment and consumables for research without paying customs or excise duty. - **Global germplasm, local adaptation** - the company has tie-ups with ICRISAT for groundnut and chickpea germplasm, CIMMYT in Mexico for maize, IRRI and Punjab Agricultural University for rice, and a Korean partner for anti-cancer cabbage, so it can screen exotic genetics and breed varieties suited to Indian conditions. - **Modern tools on old problems** - the R&D team uses marker-assisted breeding, gene editing (CRISPR/Cas9), bioinformatics, and AI-driven field analytics to accelerate yield improvement, climate resilience, and disease resistance. ## 3. Distribution and farmer reach: the last mile that closes the loop **A network of over 1,000 distributors across at least nine states, combined with depots, branch offices, and a three-stage farmer engagement model, puts seeds in the hands of growers and feeds field intelligence back to R&D.** - **Distributors as the backbone** - more than 1,000 distributors sell to a retail network of farmers across Gujarat, Maharashtra, Rajasthan, Madhya Pradesh, Uttar Pradesh, Karnataka, West Bengal, Bihar, and Punjab, with the top five customers accounting for only about 11% of revenue, so no single buyer holds sway. - **Depots and branches shorten the supply chain** - the company runs depots in eight major states and has opened branch offices in Pune, Jaipur, and Indore, putting inventory closer to farmers and reducing delivery time. - **Farmer engagement that runs all year** - the go-to-market model has three phases: pre-season village meetings to build awareness, in-season live demonstrations of harvesting and planting techniques, and off-season discussions on new farming practices, so the relationship with the farmer does not end with the sale. - **Field workers are the feedback loop** - constant communication between field staff and farmers gathers real-world performance data on varieties, which flows directly back to the R&D team to shape the next breeding cycle. - **Seasonality shapes the rhythm** - the operating cycle stretches to 203 days because the company must build large inventory in the fourth quarter to be ready for the Kharif sowing season starting in June, making working-capital management a structural feature of the business. # Group structure and partners **The company is a single listed entity with no subsidiaries, run by a family leadership team and connected to two sister concerns through routine seed trading.** - **One company, one listing** - Bombay Super Hybrid Seeds Limited is a standalone public company with no subsidiaries or joint ventures, and its equity trades on the main board of the National Stock Exchange. - **Family at the helm** - Arvindkumar Kakadia (Managing Director & Chairman) drives strategy, expansion, and government approvals; Kiritkumar Kakadia (Whole-time Director & CFO) handles finance, HR, and distribution; and Hemang Baxi leads R&D. - **Sister concerns trade seeds** - the company buys from and sells seeds to Upsurge Seeds of Agriculture Limited and American Genetics Seeds Limited, both sister concerns, in related-party transactions conducted at arm’s length.

Documents — Bombay Super Hybrid Seeds Ltd

  • Q3 FY2023 Earnings Call Transcript (Dec 2022, PDF): https://www.stockscans.in/document/mawfaea4hxnlhc0kiyncaz0e.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/igs4d7h1d3okera2waek4qho.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/ah09225kq54eucw2w9io0lpz.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/9d5yqhsjij1ac3x5c5iq80f3.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/tq8xqilj8duocb41q80fl766.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/tfge2d5aohiufru27qnmaaon.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/yr53806x4exzui2ve2gt5e22.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/1jc6ll6bcmh8mt9cyy5wb261.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/lj8szgk56k6vr7jmgpopy0c7.pdf
  • Q3 FY2024 Investor Presentation (Dec 2023, PDF): https://www.stockscans.in/document/1kg0r4j1jsa1sb0n8t6sfxmq.pdf
  • Q3 FY2023 Investor Presentation (Dec 2022, PDF): https://www.stockscans.in/document/5lq6bpkwwp4y6ovxh7mzsjag.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/zv6yiocydl4u1hj7xtgytoyh.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/hy7pff0po6rm154ash2enu54.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/9wf3tbkg06fotlm8vjlk5pq8.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/8i06w96s4px6seub6jezyo2t.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/746afaaqp1ugaei1ccrjkv6e.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/kelfjhqii395ru53exf31mff.pdf

Concall Transcript Summaries — Bombay Super Hybrid Seeds Ltd

  • Q3 FY2023 Concall Transcript Summary (Dec 2022): https://www.stockscans.in/company/NSE%3ABSHSL/transcript-notes/202212/mawfaea4hxnlhc0kiyncaz0e.pdf